Please contact us for more information or to learn if you are eligible to participate.
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread to other places in the body (metastatic).
Principal Investigator | Dr. Narmala |
Co-PI | Edgar Lopez Pacheco |
Sponsor | National Cancer Institute (NCI) |
Type of Trial | Interventional |